Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adult Stem Cells01:33

Adult Stem Cells

33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Primary Active Transport01:47

Primary Active Transport

199.4K
In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
199.4K
Primary Active Transport01:29

Primary Active Transport

14.4K
In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction they would...
14.4K
Primary and Secondary Growth in Roots and Shoots03:02

Primary and Secondary Growth in Roots and Shoots

60.6K
Vascular plants, which account for over 90% of the Earth’s vegetation, all undergo primary growth—which lengthens roots and shoots. Many land plants, notably woody plants, also undergo secondary growth—which thickens roots and shoots.
60.6K
Primary Production01:06

Primary Production

25.3K
The total amount of energy acquired by primary producers in an ecosystem is called gross primary production (GPP). However, of this energy, producers use some for metabolic processes, and some is lost as heat, decreasing the amount of energy available to the next trophic level. The remaining usable amount of energy is called the net primary productivity (NPP). In terrestrial ecosystems, NPP is driven by climate, while light penetration and nutrient availability drive NPP in aquatic ecosystems.
25.3K
Primary Distribution01:28

Primary Distribution

547
Primary distribution systems deliver electrical power from substations to consumers through various voltage classes, with 15-kV class voltages being predominant among U.S. utilities. Older 2.5- and 5-kV classes are being replaced by 15-kV primaries, while higher 25- to 34.5-kV classes are used in high-density urban areas and rural regions with long feeders. Three-phase, four-wire multigrounded systems are widely employed for balanced power delivery, using the neutral wire as a grounding point.
547

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicopathologic characterization of a non-expansile, epilepsy-associated neocortical lesion with BRAF K601E mutation.

Journal of neuropathology and experimental neurology·2026
Same author

Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification.

Nature communications·2026
Same author

Primary intracranial sarcomas in Peruvian children: a high-incidence clinicopathological series from a National Reference Center.

Ecancermedicalscience·2026
Same author

Stratification by Ki-67 Labeling Index Increases Specificity of p16<sup>INK4a</sup> Expression as a Surrogate Marker for CDKN2A Inactivation in Meningioma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

IL6 Supports Development of an Immunosuppressive Microenvironment and Resistance to Therapy in Glioblastoma.

Cancer research·2026

Related Experiment Video

Updated: Feb 7, 2026

Electrochemotherapy of Tumours
03:57

Electrochemotherapy of Tumours

Published on: December 15, 2008

25.1K

Primary brain tumours in adults.

Sarah Lapointe1, Arie Perry2, Nicholas A Butowski1

  • 1Department of Neurological Surgery, University of California, San Francisco, CA, USA.

Lancet (London, England)
|August 1, 2018
PubMed
Summary

Malignant brain tumors, particularly gliomas, are challenging to treat. Advances in molecular biology and neuro-oncology offer new diagnostic and therapeutic strategies, but combination therapies are needed for better outcomes.

More Related Videos

Electrophysiological Recording in the Brain of Intact Adult Zebrafish
09:42

Electrophysiological Recording in the Brain of Intact Adult Zebrafish

Published on: November 19, 2013

22.3K
Whole Cell Recordings from Brain of Adult Drosophila
09:27

Whole Cell Recordings from Brain of Adult Drosophila

Published on: July 29, 2007

17.0K

Related Experiment Videos

Last Updated: Feb 7, 2026

Electrochemotherapy of Tumours
03:57

Electrochemotherapy of Tumours

Published on: December 15, 2008

25.1K
Electrophysiological Recording in the Brain of Intact Adult Zebrafish
09:42

Electrophysiological Recording in the Brain of Intact Adult Zebrafish

Published on: November 19, 2013

22.3K
Whole Cell Recordings from Brain of Adult Drosophila
09:27

Whole Cell Recordings from Brain of Adult Drosophila

Published on: July 29, 2007

17.0K

Area of Science:

  • Neuro-oncology
  • Genomics
  • Cancer immunology

Background:

  • Primary central nervous system (CNS) tumors are diverse, with malignant types like gliomas having poor prognoses.
  • Malignant gliomas are the most common primary brain tumors in adults, characterized by poor survival rates.
  • Understanding glioma pathogenesis has been advanced by molecular biology, identifying key genetic alterations.

Purpose of the Study:

  • To highlight the impact of molecular biology and genomics on neuro-oncology.
  • To discuss the potential of new diagnostic and therapeutic strategies for brain tumors.
  • To emphasize the need for translating research advances into effective clinical treatments.

Main Methods:

  • Review of recent advances in molecular biology, genomics, and CNS immunology.
  • Analysis of the revised 2016 WHO classification of CNS tumors incorporating molecular alterations.
  • Examination of current therapeutic approaches including targeted therapies, immunotherapies, and gene therapies.

Main Results:

  • Specific genetic alterations (IDH, 1p/19q codeletion, H3 Lys27Met, RELA-fusion) are now integrated into brain tumor classification.
  • Genomic and immunological advancements herald a new era in neuro-oncology with promise for diagnosis and treatment.
  • Single-agent therapies have shown limited success, indicating the necessity of combination therapies.

Conclusions:

  • Molecular understanding is crucial for the diagnosis, grading, and treatment of brain tumors.
  • Translating scientific advances into effective treatments remains a significant challenge.
  • Biomarker-targeted clinical trials are essential for efficient therapeutic development and achieving durable anti-tumor responses.